Steglatro

Active Ingredient(s): Ertugliflozin
FDA Approved: * December 19, 2017
Pharm Company: * MERCK SHARP DOHME
Category: Diabetes

Ertugliflozin, sold under the brand name Steglatro, is a medication for the treatment of type 2 diabetes.[2][3] The most common side effects include fungal infections of the vagina and other infections of the female reproductive system.[3] Ertugliflozin is a sodium/glucose cotransporter 2 (SGLT2) inhibitor[2][3] and is in the class of drugs known as gliflozins.[4] In the United States, it was appro... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Steglatro 5 mg Oral Tablet, Film Coated
NDC: 0006-5363
Labeler:
Merck Sharp & Dohme Corp.
Steglatro 15 mg Oral Tablet, Film Coated
NDC: 0006-5364
Labeler:
Merck Sharp & Dohme Corp.
Steglatro 5 mg Oral Tablet, Film Coated
NDC: 50090-6182
Labeler:
A-s Medication Solutions
Steglatro 15 mg Oral Tablet, Film Coated
NDC: 50090-6183
Labeler:
A-s Medication Solutions